$143.95
+
$6.01 (4.18%)
End-of-day quote: 04/30/2024
NasdaqGS:ALNY
Alnylam Pharmaceuticals Inc Annual Report
| Year | Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$1.83B | $1.04B | $844.29M | $492.85M | $219.75M | $74.91M | $89.91M | $47.16M | $41.10M | $50.56M | $47.17M | $66.73M | $82.76M | $100.04M | $100.53M | $96.16M | $50.90M | $26.93M | $5.72M | $4.28M | |
| GM % | Gross Margin % |
|
83.02% | 83.73% | 83.40% | 84.16% | 88.60% | 97.59% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | |
| OM | Operating Margin |
|
-15.43% | -75.68% | -83.93% | -168.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -197.05% | -91.04% | -66.24% | -41.86% | -47.86% | -28.95% | -183.07% | -146.68% | 0.00% | 0.00% | |
| EPS | Earnings Per Share |
|
$0.00 | $-1.72 | $-6.50 | $-6.14 | $-6.38 | $-6.70 | $-6.21 | $-5.42 | $-4.79 | $-3.45 | $-1.88 | $-1.45 | $-2.11 | $-1.35 | $-1.04 | $-1.14 | $-0.64 | $-2.21 | $-1.09 | $-1.74 | $-2.75 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
-0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.00% | 0 | 0 | |
| Sha. | Shares |
|
125.79m | 123.93m | 120.18m | 116.43m | 112.19m | 101.18m | 99.67m | 85.94m | 85.09m | 77.2m | 63.74m | 52.49m | 42.72m | 42.34m | 41.84m | 41.41m | 40.77m | 37.05m | 26.64m | 20.85m | |
| OCF | Operating Cash Flow |
|
$0.00M | $-541.27M | $-641.69M | $-614.96M | $-278.43M | $-562.62M | $-382.79M | $-307.70M | $-189.14M | $-165.64M | $-68.66M | $-115.61M | $-87.07M | $-84.34M | $-72.15M | $65.49M | $196.52M | $-24.63M | $-16.49M | $-19.57M | |
| FCF | Free Cash Flow |
|
$-97.12M | $-613.33M | $-718.07M | $-685.32M | $-418.58M | $-689.50M | $-487.00M | $-372.26M | $-202.09M | $-174.60M | $-72.66M | $-123.96M | $-88.90M | $-89.07M | $-77.10M | $54.73M | $188.73M | $-29.62M | $-18.44M | $-28.58M | |
| FCFS | Free Cash Flow Per Share |
|
$0.00 | $-5.04 | $-6.06 | $-5.96 | $-3.83 | $-6.85 | $-5.38 | $-4.35 | $-2.41 | $-2.35 | $-1.18 | $-2.47 | $-2.08 | $-2.12 | $-1.85 | $1.33 | $4.88 | $-0.93 | $-0.84 | $-2.40 |
